Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

stage IV uterine sarcoma

Known as: uterine sarcoma, metastatic, uterine sarcoma, stage IV, metastatic uterine sarcoma 
Stage IV includes: IVA (T4, Any N, M0); IVB (Any T, Any N, M1). T4: Tumor involves bladder or rectum. M0: No distant metastasis. M1: Distal… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Seven cases of actinomycotic endometritis were identified among 28,906 endometrial biopsies performed in the last 10 yr. The… Expand
Is this relevant?
2019
2019
PURPOSE Uterine sarcoma accounts for 3-9% of uterine malignant tumors and has poor prognosis. Pazopanib is an oral multi-kinase… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2018
2018
Objective In the treatment of metastatic soft tissue sarcoma (STS), pazopanib is considered a standard treatment after failure of… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2015
2015
Uterine sarcomas are rare and aggressive gynecologic tumors with a poor prognosis because of recurrence and metastasis. However… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Review
2013
Review
2013
AIM To gain more information about the knowledge of the clinical management of uterine sarcoma. MATERIALS AND METHODS This… Expand
Is this relevant?
Review
2013
Review
2013
Background: Undifferentiated uterine sarcoma (UUS) is a rare tumor with an aggressive growth pattern. They occur in women from 40… Expand
  • figure 1
  • figure 2
  • figure 4
Is this relevant?
Review
2006
Review
2006
15053 Background: The prognosis of metastatic uterine sarcoma is poor with median survival reported between 4 to 26 months. We… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2004
Review
2004
5105 Background: Uterine sarcomas are rare and management of metastatic disease often conforms to treatment practice for other… Expand
Is this relevant?
Review
2004
Review
2004
5143 Background: The prognosis of metastatic uterine sarcoma is poor with median survival reported between 4-26 months. The… Expand
Is this relevant?
1956
1956
Abstract A report is cited of a patient with sarcoma presumedly metastatic to the lung. Treatment consisted of total… Expand
Is this relevant?